1. Home
  2. MASI vs RGEN Comparison

MASI vs RGEN Comparison

Compare MASI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MASI
  • RGEN
  • Stock Information
  • Founded
  • MASI 1989
  • RGEN 1981
  • Country
  • MASI United States
  • RGEN United States
  • Employees
  • MASI N/A
  • RGEN N/A
  • Industry
  • MASI Medical/Dental Instruments
  • RGEN Medical/Dental Instruments
  • Sector
  • MASI Health Care
  • RGEN Health Care
  • Exchange
  • MASI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • MASI 8.2B
  • RGEN 8.0B
  • IPO Year
  • MASI 2007
  • RGEN N/A
  • Fundamental
  • Price
  • MASI $153.15
  • RGEN $128.04
  • Analyst Decision
  • MASI Buy
  • RGEN Buy
  • Analyst Count
  • MASI 6
  • RGEN 12
  • Target Price
  • MASI $187.00
  • RGEN $172.67
  • AVG Volume (30 Days)
  • MASI 630.6K
  • RGEN 830.2K
  • Earning Date
  • MASI 05-06-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • MASI N/A
  • RGEN N/A
  • EPS Growth
  • MASI N/A
  • RGEN N/A
  • EPS
  • MASI N/A
  • RGEN N/A
  • Revenue
  • MASI $2,126,800,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • MASI N/A
  • RGEN $13.93
  • Revenue Next Year
  • MASI $7.82
  • RGEN $14.35
  • P/E Ratio
  • MASI N/A
  • RGEN N/A
  • Revenue Growth
  • MASI 16.68
  • RGEN 4.88
  • 52 Week Low
  • MASI $101.61
  • RGEN $102.97
  • 52 Week High
  • MASI $194.88
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • MASI 44.29
  • RGEN 44.98
  • Support Level
  • MASI $142.80
  • RGEN $123.10
  • Resistance Level
  • MASI $165.28
  • RGEN $135.47
  • Average True Range (ATR)
  • MASI 5.17
  • RGEN 6.85
  • MACD
  • MASI -0.03
  • RGEN -0.74
  • Stochastic Oscillator
  • MASI 40.09
  • RGEN 19.54

About MASI Masimo Corporation

Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: